METHOD FOR ASSESSING TCR T CELL THERAPY DESIGNED TO TARGET AN NY-ESO-1 ANTIGEN Application WO-2023203506-A1 World Intellectual Property Organisation (WIPO) 26 Oct 2023
ADOPTIVE CELL TRANSFER AND ONCOLYTIC VIRUS COMBINATION THERAPY Application EP-4197551-A2 European Patent Office 21 Jun 2023
ADOPTIVE CELL TRANSFER AND ONCOLYTIC VIRUS COMBINATION THERAPY Application WO-2017219150-A1 World Intellectual Property Organisation (WIPO) 28 Dec 2017